BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 38015750)

  • 1. Modeling Molecular Pathogenesis of Idiopathic Pulmonary Fibrosis-Associated Lung Cancer in Mice.
    Barravecchia I; Lee JM; Manassa J; Magnuson B; Ferris SF; Cavanaugh S; Steele NG; Espinoza CE; Galban CJ; Ramnath N; Frankel TL; Pasca di Magliano M; Galban S
    Mol Cancer Res; 2024 Mar; 22(3):295-307. PubMed ID: 38015750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-326-mediated overexpression of NFIB offsets TGF-β induced epithelial to mesenchymal transition and reverses lung fibrosis.
    Pattnaik B; Negi V; Chaudhuri R; Desiraju K; Faizan MI; Akhtar A; Ansari MS; Shakir M; Gheware A; Prakash YS; Guleria R; Ghosh B; Agrawal A; Ahmad T
    Cell Mol Life Sci; 2023 Nov; 80(12):357. PubMed ID: 37950757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased expression of OPN contributes to idiopathic pulmonary fibrosis and indicates a poor prognosis.
    Ji J; Zheng S; Liu Y; Xie T; Zhu X; Nie Y; Shen Y; Han X
    J Transl Med; 2023 Sep; 21(1):640. PubMed ID: 37726818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Bleomycin Model of Pulmonary Fibrosis.
    Liu T; De Los Santos FG; Phan SH
    Methods Mol Biol; 2017; 1627():27-42. PubMed ID: 28836192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD148 Deficiency in Fibroblasts Promotes the Development of Pulmonary Fibrosis.
    Tsoyi K; Liang X; De Rossi G; Ryter SW; Xiong K; Chu SG; Liu X; Ith B; Celada LJ; Romero F; Robertson MJ; Esposito AJ; Poli S; El-Chemaly S; Perrella MA; Shi Y; Whiteford J; Rosas IO
    Am J Respir Crit Care Med; 2021 Aug; 204(3):312-325. PubMed ID: 33784491
    [No Abstract]   [Full Text] [Related]  

  • 6. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition.
    Guo X; Adeyanju O; Sunil C; Mandlem V; Olajuyin A; Huang S; Chen SY; Idell S; Tucker TA; Qian G
    Am J Physiol Cell Physiol; 2022 Jul; 323(1):C133-C144. PubMed ID: 35584329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and validation of chemokine system-related genes in idiopathic pulmonary fibrosis.
    Zhao T; Wu X; Zhao X; Yao K; Li X; Ni J
    Front Immunol; 2023; 14():1159856. PubMed ID: 37122736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WNT1-inducible signaling protein-1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis.
    Königshoff M; Kramer M; Balsara N; Wilhelm J; Amarie OV; Jahn A; Rose F; Fink L; Seeger W; Schaefer L; Günther A; Eickelberg O
    J Clin Invest; 2009 Apr; 119(4):772-87. PubMed ID: 19287097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deficiency of HtrA3 Attenuates Bleomycin-Induced Pulmonary Fibrosis Via TGF-β1/Smad Signaling Pathway.
    Li G; Shen C; Wei D; Yang X; Jiang C; Yang X; Mao W; Zou J; Tan J; Chen J
    Lung; 2023 Apr; 201(2):235-242. PubMed ID: 36823409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of fibroblast growth factor 23 and klotho cross talk in idiopathic pulmonary fibrosis.
    Barnes JW; Duncan D; Helton S; Hutcheson S; Kurundkar D; Logsdon NJ; Locy M; Garth J; Denson R; Farver C; Vo HT; King G; Kentrup D; Faul C; Kulkarni T; De Andrade JA; Yu Z; Matalon S; Thannickal VJ; Krick S
    Am J Physiol Lung Cell Mol Physiol; 2019 Jul; 317(1):L141-L154. PubMed ID: 31042083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allies or enemies? The effect of regulatory T cells and related T lymphocytes on the profibrotic environment in bleomycin-injured lung mouse models.
    Seyran M; Melanie S; Philip S; Amiq G; Fabian B
    Clin Exp Med; 2023 Aug; 23(4):1075-1088. PubMed ID: 36403186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of Family with Sequence Similarity 13, Member A Exacerbates Pulmonary Fibrosis Potentially by Promoting Epithelial to Mesenchymal Transition.
    Rahardini EP; Ikeda K; Nugroho DB; Hirata KI; Emoto N
    Kobe J Med Sci; 2020 Jan; 65(3):E100-E109. PubMed ID: 32029695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose-derived mesenchymal stem cell therapy for reverse bleomycin-induced experimental pulmonary fibrosis.
    Zhao X; Wu J; Yuan R; Li Y; Yang Q; Wu B; Zhai X; Wang J; Magalon J; Sabatier F; Daumas A; Zhu WM; Zhu N
    Sci Rep; 2023 Aug; 13(1):13183. PubMed ID: 37580529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biochanin-A ameliorates pulmonary fibrosis by suppressing the TGF-β mediated EMT, myofibroblasts differentiation and collagen deposition in in vitro and in vivo systems.
    Andugulapati SB; Gourishetti K; Tirunavalli SK; Shaikh TB; Sistla R
    Phytomedicine; 2020 Nov; 78():153298. PubMed ID: 32781391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
    Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
    Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atractylodin Suppresses TGF-β-Mediated Epithelial-Mesenchymal Transition in Alveolar Epithelial Cells and Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
    Chang KW; Zhang X; Lin SC; Lin YC; Li CH; Akhrymuk I; Lin SH; Lin CC
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High complement protein C1q levels in pulmonary fibrosis and non-small cell lung cancer associated with poor prognosis.
    Kou W; Li B; Shi Y; Zhao Y; Yu Q; Zhuang J; Xu Y; Peng W
    BMC Cancer; 2022 Jan; 22(1):110. PubMed ID: 35078421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
    Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
    J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinases as therapeutic targets for idiopathic pulmonary fibrosis.
    Craig VJ; Zhang L; Hagood JS; Owen CA
    Am J Respir Cell Mol Biol; 2015 Nov; 53(5):585-600. PubMed ID: 26121236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of ANT1 Increases Fibrosis and Epithelial Cell Senescence in Idiopathic Pulmonary Fibrosis.
    Sui J; Boatz JC; Shi J; Hu Q; Li X; Zhang Y; Königshoff M; Kliment CR
    Am J Respir Cell Mol Biol; 2023 Nov; 69(5):556-569. PubMed ID: 37487137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.